Newsroom

Press Release & Public Notice

The Food and Drugs Authority (FDA) is notifying healthcare professionals and the public of a
The Food and Drugs Authority (FDA) is alerting the public about a recent major incidence
The attention of the Food and Drugs Authority (FDA) has been drawn to the recall
Press Release And Public Notice

Press Release And Public Notice

Drugs and Nutraceutical Products

wdt_ID wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at Date Product Name Product Type
1 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:21 AM 2020-05-08 Aba+Lami Tabs. 600+300mg-SMPC Drug
2 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:40 AM 2020-05-15 Abacavir Lamivudine 120,60 mg tablet Drug
3 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:38 AM 2020-05-15 Abevmy 25 mg per mL or 100 mg per 4 mL or 400 mg per 16 mL concentrates for Solution for Infusion in a vial (Bevacizumab, recombinant humanized monoclonal antibody) Biosimilar
4 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:34 AM 2020-05-15 Alazole 400mg Tablet (Albendazole) Drug
5 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:32 AM 2020-05-15 Aldomet 250 mg Tablets (Methyldopa) Drug
6 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:30 AM 2020-05-15 Amaryl 1 mg Tablet (Glimepiride) Drug
7 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:29 AM 2020-05-15 Amaryl 1,2,3,4 mg tablet (Glimepiride) Drug
8 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:27 AM 2020-05-15 Amaryl 2 mg Tablet (Glimepiride) Drug
9 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:26 AM 2020-05-15 Amaryl 3 mg Tablet (Glimepiride) Drug
10 prmis 12/09/2024 10:13 PM prmis 13/09/2024 12:24 AM 2020-05-15 Amaryl 4 mg Tablet (Glimepiride) Drug